Track Scribe Therapeutics's total liabilities ($63M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), SCTX shows a total liabilities of $63M. Scroll down for historical charts and peer comparison views.
Tracking SCTX's total liabilities over time shows whether Scribe Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $63M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Scribe Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $63M) with ownership activity and broader fundamentals.
Scribe Therapeutics's total liabilities is $63M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.